Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013.

doi:10.1093/cid/civ872

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 15 Dec 2015

Payne Daniel C, Selvarangan Rangaraj, Azimi Parvin H, Boom Julie A, Englund Janet A, Staat Mary Allen, Halasa Natasha B, Weinberg Geoffrey A, Szilagyi Peter G, Chappell James, McNeal Monica, Klein Eileen J, Sahni Leila C, Johnston Samantha H, Harrison Christopher J, Baker Carol J, Bernstein David I, Moffatt Mary E, Tate Jacqueline E, Mijatovic-Rustempasic Slavica, Esona Mathew D, Wikswo Mary E, Curns Aaron T, Sulemana Iddrisu, Bowen Michael D, Gentsch Jon R, Parashar Umesh D

Abstract excerpt

BACKGROUND: Using a multicenter, active surveillance network from 2 rotavirus seasons (2012 and 2013), we assessed the vaccine effectiveness of RV5 (RotaTeq) and RV1 (Rotarix) rotavirus vaccines in preventing rotavirus gastroenteritis hospitalizations and emergency department (ED) visits for numerous demographic and secular strata. METHODS: We enrolled children hospitalized or visiting the ED with acute...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enzyme-Linked Immunosorbent Assay

Share to Epidemiological Monitoring

Share to Gastroenteritis

Share to Hospitalization

Share to Rotavirus Infections

Share to Rotavirus Vaccines

Share to Vaccines, Attenuated

Source

Open in PubMed Open full text

Identifiers

PMID: 26449565
DOI: 10.1093/cid/civ872
PMCID: PMC7724934

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013.PMID 26449565Read ↗

Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011.Semantic proximity Read ↗

Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting.Semantic proximity Read ↗

Impact of rotavirus vaccines on rotavirus disease.Semantic proximity Read ↗

Continued Evidence of the Impact of Rotavirus Vaccine in Children Less Than 3 Years of Age From the United States New Vaccine Surveillance Network: A Multisite Active Surveillance Program, 2006-2016.Semantic proximity Read ↗

Rotavirus genotypes and clinical outcome of natural infection based on vaccination status in the post-vaccine era.Semantic proximity Read ↗

Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children.Semantic proximity Read ↗

Strain diversity plays no major role in the varying efficacy of rotavirus vaccines: an overview.Semantic proximity Read ↗

Sustained Effectiveness of Rotavirus Vaccine Against Very Severe Rotavirus Disease Through the Second Year of Life, Bolivia 2013-2014.Semantic proximity Read ↗

Rotavirus vaccine effectiveness in preventing hospitalizations due to gastroenteritis: a descriptive epidemiological study from Germany.Semantic proximity Read ↗

Rotavirus epidemiology 5-6 years after universal rotavirus vaccination: persistent rotavirus activity in older children and elderly.Semantic proximity Read ↗

Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.Semantic proximity Read ↗

Rotavirus Genotypes and Vaccine Effectiveness from a Sentinel, Hospital-Based, Surveillance Study for Three Consecutive Rotavirus Seasons in Lebanon.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.